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department anytime during 2010 and at least one readmission within 30 days were 
included. A multivariate marginal Cox model using clustering of admissions within 
patients was employed to test the association between DHR and LOS. Results: 
16,922 readmitted patients with a total of 27,057 readmissions comprised the study’s 
cohort. Of these, 2,015 (11.9%) had a DHR. Factors that were associated with DHRs: 
index hospital size (OR: 2.60 and 1.28 for small and medium hospitals, compared 
to large), younger age (age 18-44, OR= 1.7), being male (OR= 1.13) and long LOS (8+ 
days) in the index hospitalization (OR= 1.33). Residency in a nursing home and 
chronic conditions like COPD, Asthma, Disability and Alcohol were associated with 
a decreased likelihood of DHRs. The mean LOS in same-hospital readmissions was 
shorter by almost one day as compared with the mean LOS for DHRs, 6.1 (95% CI: 
6.0-6.2) vs. 6.9 (95% CI: 6.6-7.2), respectively. One of the strongest predictors of longer 
LOS was DHR (HR= 0.88 p< 0.001). ConClusions: Adjusting to key confounders, 
when readmission is to a different-hospital than the index admission, there is 
increased average LOS. Such an outcome can signify breakdowns in continuity of 
care and a need to create more seamless care processes when patients are readmit-
ted to a different hospital.
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objeCtives: In the fall of 2009, two Canadian provinces, BC and Alberta, allowed 
pharmacists to deliver immunizations (policy provinces), while other provinces 
across the country either did not change their legislation or implemented this pol-
icy after 2010 (non-policy provinces). The purpose of this study was to investigate 
the impact of pharmacist delivered immunizations on influenza immunization 
rates. We also evaluated perceptions of individuals around the need for immuni-
zation in those provinces that changed policy in 2009 compared to those that did 
not. Methods: The Canadian Community Health Survey (CCHS) is a nationally 
representative survey that reports results every two years. With respect to influenza 
immunization, respondents were asked whether or not they received an immuniza-
tion in the past year and if not, they were asked if they believe immunization was 
unnecessary. Hierarchical logistic regression was employed, clustering respondents 
by province of residence, to examine trends in these two outcomes from 2007/08 
(prior to policy implementation) to 2009/10 (after policy implementation). Results: 
Between 2007/08 and 2009/10, the adjusted odds of getting an influenza immuniza-
tion decreased by 22% (p< 0.01) in non-policy provinces, but increased by 4% (p= 0.06) 
in policy-provinces. The adjusted odds of ‘thinking an immunization is unneces-
sary’ increased across Canada, but at a slower rate in provinces that received the 
policy. The odds of ‘thinking an immunization is unnecessary’ increased by 27% 
(p< 0.01) in non-policy provinces compared to a 6% (p< 0.05) increase in policy-prov-
inces. ConClusions: Our findings suggest that the pharmacist immunization pol-
icy has not yet remarkably improved immunization rates, but may have prevented 
a more severe decline that was experienced by non-policy provinces. It may have 
contributed to a smaller increase in perception that immunization is unneces-
sary relative to non-policy provinces. Further research is needed to ensure that 
pharmacist delivered immunization improves population level immunization rates.
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objeCtives: The prevalence of diabetes mellitus (DM) is about 11.3% among 
adult residents in Singapore. Diabetic retinopathy (DR) is the leading cause of 
blindness among diabetic patients. In Singapore, annual screening for DR using 
retinal photograph is suggested for all diagnosed DM patients regardless of their 
risks of developing DR. This study aimed to develop and validate a prognostic 
model to stratify diabetic patients into different risk groups. Methods: A pre-
dictive model was developed using retrospective data. Diabetic patients who did 
screening in NHG polyclinics in year 2010-2011 were included. Variables included 
in the model were patient demographics (age, gender, ethnic group); comorbid 
conditions (hypertension, dyslipidemia; stroke, chronic kidney disease, peripheral 
cardiovascular disease, peripheral neuropathy); duration of diabetes; average & 
maximum Hba1c level in last 1 year; treatment agents; BMI and smoking status. 
Cox regression was used to ascertain the time to development of retinopathy. 
Stepwise algorithm with Bayesian information Criteria were applied for selecting 
the best fit model. Results: Six predictors significantly predicted the time to 
develop diabetic retinopathy. Predictors ranked by their relative importance were, 
average hba1c level in last 1 year, age, stroke, duration of diabetes, dyslipidemia, 
peripheral neuropathy. Harrell’s C concordance statistic was 0.66 (95%CI: 0.63-0.69), 
and the c-statistics of ROC for 1-year DR-free was 0.73 (95%CI: 0.72-0.75), which 
showed a good discrimination power of the model. Cox-Snell residual plot showed 
the predicted time to event fit the actual time. ConClusions: A risk stratification 
model for predicting the time to develop DR among diabetic patients has been 
developed and validated to help physicians make decisions on the optimal time 
for DR screening given the patients risk profile.
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diagnoses of injury, fracture ranked the first (47.1%), followed by TBI (33.8%). 
Regarding the types of traffic accident, most of the hospitalizations (74.6%) 
were collisions with vehicles involving cars or motorcycles. Patients who aged 
more than 65 years old, and waived copayment had significantly longer LOS 
(p< 0.05). ConClusions: We found that the hospitalizations distribution of bicycle-
related injuries differed from patients’ demographic characteristics. This finding 
can be used to promote bicycle safety on preventing injuries through different 
stakeholders such as health, or transportation, and local governments.
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objeCtives: There has been an increase in employee wellness programs that 
include $0 co-pays for basic preventive medications. Although existing literature 
suggests $0 co-pays may increase adherence, there is uncertainty on how these 
programs impact total employee health care costs. This study examines the finan-
cial impact of $0 co-pays for a large integrated health care system. Methods: The 
$0 co-pay program included approximately 200 anti-hypertensive, anti-diabetic, 
and anti-lipid medications for Geisinger Health System (GHS) employees starting 
in 2007. Data is from the Geisinger Health Plan (GHP) in Pennsylvania for the years 
2005-2011. The intervention group (GHS employees who received one or more of 
the $0 co-pay drugs during the study period) were propensity score matched based 
on 2 years of baseline data to the comparison group (non-GHS employees with 
GHP coverage who received the same drugs during the same time). A 2-part multi-
variate regression model was used to estimate the per member per month (PMPM) 
dollar effect. A separate multivariate regression model estimated the incremental 
changes in drug spending associated with the $0 co-pay to calculate the return on 
investment (ROI). Results: The sample included 2,251 GHS employees (interven-
tion group) and 3,857 non-GHS employees (comparison group). The outcome vari-
able was the total medical allowed amount (amount paid by the health plan plus 
the member out-of-pocket cost) excluding the Rx drug cost. The average medical 
allowed amount among the GHS employees was reduced by $99 PMPM during the 
study period. This translated to a 12% savings over the 5-year study period relative 
to the non-GHS employee group. Considering the foregone copay and the incre-
mental drug spending associated with the $0 co-pay, our results suggest an ROI of 
1.7. ConClusions: Implementation of $0 co-pays can potentially lead to net cost 
savings. Future research needs to examine how programs might achieve cost savings 
by analyzing its impact on health.
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objeCtives: The top 5% of health care users based on total expenditures [High 
Resource Patients (HRP)] account for roughly half of all health care costs. The dis-
tribution of health care expenditures for HRP is likely to differ from the overall 
population. By examining spending patterns of HRP, we can better understand the 
components of health care expenditures that drive overall spending. Methods: 
We performed a retrospective analysis of managed care enrollees across the full 
age and care spectrum, by examining health care claims obtained from the IMS 
LifeLink Health Plan Claims (HPC) Database. A total of 15,587,257 health plan mem-
bers met our selection criteria, of which 779,364 were classified as HRP. We compared 
expenditures during CY2011 by place of service (Outpatient, Inpatient, Pharmacy) 
and payer type (Commercially insured, Medicare Advantage, and Medicaid man-
aged care) between the full population and HRP. Results: Inpatient hospitalization 
accounted for more direct health care expenditures for HRP (40.0%) than expendi-
tures from pharmacy services (18.1%) or from major outpatient places of service 
[Ambulatory Surgical Center (ASC) 20.3%, Physician Visits (PV) 4.9%, and Emergency 
Department (ED) 2.7%]. The share of overall expenditures attributed to inpatient 
services was higher for HRP compared to the full population (24.6%) while the share 
of expenditures attributed to pharmacy and outpatient services was reduced (Rx: 
21.4%, ASC: 19.7%, PV: 11.7%, ED: 4.5% in the full population). This pattern was 
observed across payer type. The use of physician-administered pharmaceuticals did 
not alter this spending pattern. ConClusions: Policy efforts to address health care 
cost inflation can only succeed if they address HRP, who drive overall health care 
spending disproportionately. Understanding patterns of spending in this popula-
tion can help in devising cost reduction strategies. Policy makers should focus on 
integrated care for HRP, including appropriate use of pharmaceuticals, so as to 
potentially reduce costly downstream inpatient expenditures.
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objeCtives: Recent studies show that about 20% of readmissions are to a different 
hospital than the index admission. In non-same hospital readmissions there exists 
a risk for fragmentation and loss of information. We aimed to test risk factors for 
different hospital readmissions (DHR) and whether DHRs are associated with worse 
outcomes, specifically longer length of stay (LOS) as compared with same hospital 
readmissions. Methods: A retrospective cohort study of hospitalized members 
of Clalit Health Services, Israel’s largest non-for-profit health care organization. 
All Clalit members that had at least one hospitalization in an internal medicine 
